Evidence map›Paper›PMID 30664629›Full record

ArticleTranslational psychiatry2019

Cognitive impairment and autistic-like behaviour in SAPAP4-deficient mice.

Claudia Schob, Fabio Morellini, Ora Ohana, Lidia Bakota, Mariya V Hrynchak, Roland Brandt, Marco D Brockmann, Nicole Cichon, Henrike Hartung, Ileana L Hanganu-Opatz and 14 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 1 country.

Claudia SchobInstitute for Human Genetics, University Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany.
Fabio MorelliniBehavioral Biology, Centre for Molecular Neurobiology Hamburg (ZMNH), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Ora OhanaInstitute for Molecular and Cellular Cognition, ZMNH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Lidia BakotaDepartment of Neurobiology, University of Osnabrück, 49076, Osnabrück, Germany.
Mariya V HrynchakDepartment of Neurobiology, University of Osnabrück, 49076, Osnabrück, Germany.
Roland BrandtDepartment of Neurobiology, University of Osnabrück, 49076, Osnabrück, Germany.
Marco D BrockmannDevelopmental Neurophysiology, Department of Neuroanatomy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Nicole CichonDevelopmental Neurophysiology, Department of Neuroanatomy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Henrike HartungDevelopmental Neurophysiology, Department of Neuroanatomy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Ileana L Hanganu-OpatzDevelopmental Neurophysiology, Department of Neuroanatomy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Vanessa KrausBehavioral Biology, Centre for Molecular Neurobiology Hamburg (ZMNH), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Sarah ScharfBehavioral Biology, Centre for Molecular Neurobiology Hamburg (ZMNH), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Irm Herrmans-BorgmeyerTransgenic Mouse Facility, ZMNH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Michaela SchweizerMorphology and Electron Microscopy, ZMNH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dietmar KuhlInstitute for Molecular and Cellular Cognition, ZMNH, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Markus WöhrBehavioral Neuroscience, Experimental and Biological Psychology, Faculty of Psychology, Philipps-University of Marburg, 35032, Marburg, Germany.ORCID http://orcid.org/0000-0001-6986-5684
Karl J VörckelBehavioral Neuroscience, Experimental and Biological Psychology, Faculty of Psychology, Philipps-University of Marburg, 35032, Marburg, Germany.
Julia Calzada-WackGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Centre Munich, German Research Centre for Environmental Health, 85764, Neuherberg, Germany.
Helmut FuchsGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Centre Munich, German Research Centre for Environmental Health, 85764, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-5143-2677
Valérie Gailus-DurnerGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Centre Munich, German Research Centre for Environmental Health, 85764, Neuherberg, Germany.
Martin Hrabě de AngelisGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Centre Munich, German Research Centre for Environmental Health, 85764, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-7898-2353
Craig C GarnerGerman Centre for Neurodegenerative Diseases (DZNE), c/o Charité University Medical Centre, 10117, Berlin, Germany.
Hans-Jürgen KreienkampInstitute for Human Genetics, University Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany.
Stefan KindlerInstitute for Human Genetics, University Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany. kindler@uke.de.
Universität Hamburg · DEHelmholtz Zentrum München · DEOsnabrück University · DEPhilipps University of Marburg · DEGerman Center for Neurodegenerative Diseases · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In humans, genetic variants of DLGAP1-4 have been linked with neuropsychiatric conditions, including autism spectrum disorder (ASD). While these findings implicate the encoded postsynaptic proteins, SAPAP1-4, in the etiology of neuropsychiatric conditions, underlying neurobiological mechanisms are unknown. To assess the contribution of SAPAP4 to these disorders, we characterized SAPAP4-deficient mice. Our study reveals that the loss of SAPAP4 triggers profound behavioural abnormalities, including cognitive deficits combined with impaired vocal communication and social interaction, phenotypes reminiscent of ASD in humans. These behavioural alterations of SAPAP4-deficient mice are associated with dramatic changes in synapse morphology, function and plasticity, indicating that SAPAP4 is critical for the development of functional neuronal networks and that mutations in the corresponding human gene, DLGAP4, may cause deficits in social and cognitive functioning relevant to ASD-like neurodevelopmental disorders.

Indexed as

AnimalsAutism Spectrum DisorderBehavior, AnimalCognitive DysfunctionDisease Models, AnimalFemaleInterpersonal RelationsMaleMiceMice, KnockoutNerve Tissue ProteinsNeuronsSAP90-PSD95 Associated ProteinsSocial BehaviorSynapsesDlgap4 protein, mouseNerve Tissue ProteinsSAP90-PSD95 Associated Proteins

Identifiers

PMID30664629
PMCPMC6341115
OpenAlexW2917608289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.